药约约垃圾骗子app
药约约垃圾骗子app
Description
药约約是好医生药业集团旗下专销药品直卖网，没有中间商赚差价，一年为会员客户节约采购成本至少10万元。并且专销做的更好，质量有保障，好医生品牌值得信赖！平台业务已覆盖全国所有省份数十万家终端药店及诊所，帮助基层客户实现价值，助力基层终端成为名医名店。
Screenshots
药约約 FAQ
-
Is 药约約 free?
Yes, 药约約 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 药约約 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 药约約 cost?
药约約 is free.
-
What is 药约約 revenue?
To get estimated revenue of 药约約 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
药约約 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
药约約 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
药易购-合纵药品采购
正规药品采购、批发、销售网上药品交易电子商务平台
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
药采采
让每一位好中医 都能用上好中药
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
药真汇 - 平价大药房
专营药品零售
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
青春康源
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
万岁健康
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
汇采药
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
汇仁多培康
dpk
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
中傲大健康
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
金沛方
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
药发采
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago |
药约約 Installs
Last 30 days
药约約 Revenue
Last 30 days药约約 Revenue and Downloads
Gain valuable insights into 药约約 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Shopping
- Publisher
- Sichuan XinJiaNengDa Pharmaceutical Co
- Languages
- Arabic, English, French, German, Indonesian, Italian, Japanese, Korean, Malay, Portuguese, Russian, Chinese, Spanish, Thai, Chinese, Turkish, Vietnamese
- Recent release
- 2.7.45 (1 week ago )
- Released on
- Apr 21, 2020 (4 years ago )
- Also available in
- China , Mexico , Philippines , Peru , New Zealand , Norway , Netherlands , Nigeria , Malaysia , Pakistan , Madagascar , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Italy , Iceland , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , India
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.